Literature DB >> 25319977

Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistry.

Carol C Cheung1, Diponkar Banerjee2, Penny J Barnes3, Richard C Berendt4, Jagdish Butany1, Sarah Canil4, Blaise A Clarke1, Hala El-Zimaity1, John Garratt5, Laurette Geldenhuys3, C Blake Gilks5, Lisa Manning6, Michael Mengel7, Bayardo Perez-Ordonez1, Dragana Pilavdzic8, Robert Riddell9, Paul E Swanson10, Emina E Torlakovic11.   

Abstract

OBJECTIVES: Formalin-fixed, paraffin-embedded unstained archived diagnostic tissue sections are frequently exchanged between clinical laboratories for immunohistochemical staining. The manner in which such sections are prepared represents a type of preanalytical variable that must be taken into account given the growing importance of immunohistochemical assays, especially predictive and prognostic tests, in personalized medicine.
METHODS: Recommendations were derived from review of the literature and expert consensus of the Canadian Association of Pathologists-Association canadienne des pathologists National Standards Committee for High Complexity Testing/Immunohistochemistry.
RESULTS: Relevant considerations include the type of glass slide on which to mount the unstained sections; the thickness of the tissue sections; the time from slide preparation to testing; the environment, particularly the temperature at which the unstained sections will be maintained prior to testing; the inclusion of on-slide positive control tissue where possible; and whether patient identifier(s) should be included on slide labels.
CONCLUSIONS: Clear communication between requesting and releasing laboratories will facilitate the proper preparation of unstained sections and also ensure that applicable privacy considerations are addressed. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Archived diagnostic tissue; Guidelines; Immunohistochemistry; Unstained sections

Mesh:

Substances:

Year:  2014        PMID: 25319977     DOI: 10.1309/AJCP77GXYVEQXMXT

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data.

Authors:  Felicitas Oberndorfer; Sarah Moling; Leonie Annika Hagelkruys; Christoph Grimm; Stephan Polterauer; Alina Sturdza; Stefanie Aust; Alexander Reinthaller; Leonhard Müllauer; Richard Schwameis
Journal:  J Pers Med       Date:  2021-01-15

2.  Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer.

Authors:  Gerda Hofstetter; Christina Grech; Dietmar Pils; Johannes Pammer; Barbara Neudert; Nina Pötsch; Pascal Baltzer; Tatjana Traub-Weidinger; Veronika Seebacher; Stefanie Aust
Journal:  J Pers Med       Date:  2022-03-31

3.  Epitope Preservation Methods for Tissue Microarrays: Longitudinal Prospective Study.

Authors:  Nicole K Andeen; Regina Bowman; Toni Baullinger; J Mathew Brooks; Maria S Tretiakova
Journal:  Am J Clin Pathol       Date:  2017-11-02       Impact factor: 2.493

4.  Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP).

Authors:  Carol C Cheung; Penny Barnes; Gilbert Bigras; Scott Boerner; Jagdish Butany; Fiorella Calabrese; Christian Couture; Jean Deschenes; Hala El-Zimaity; Gabor Fischer; Pierre O Fiset; John Garratt; Laurette Geldenhuys; C Blake Gilks; Marius Ilie; Diana Ionescu; Hyun J Lim; Lisa Manning; Adnan Mansoor; Robert Riddell; Catherine Ross; Sinchita Roy-Chowdhuri; Alan Spatz; Paul E Swanson; Victor A Tron; Ming-Sound Tsao; Hangjun Wang; Zhaolin Xu; Emina E Torlakovic
Journal:  Appl Immunohistochem Mol Morphol       Date:  2019 Nov/Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.